AQP3 and breast carcinoma: However, confirmation that a particular drug-modulated gene specifically contributes to drug response requires detailed analysis similar to that performed for AQP3, a gene up-regulated by the 5-FU precursor and capecitabine catabolite, 5′-DFUR, in the breast cancer cell line MCF7[4].